James Arthur Bristol insider trades

Open-market stock purchases and sales by James Arthur Bristol, Director at Ernexa Therapeutics Inc, from SEC Form 4 filings since Oct 2, 2017.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +239%.

Recent trades

DateStockTradeValue
Aug 31, 2026ERNA Ernexa Therapeutics IncBought (not open market)—
Aug 31, 2026ERNA Ernexa Therapeutics IncBought (not open market)—
Jun 26, 2026ERAS Erasca, IncBought (not open market)—
Jan 1, 2026ERAS Erasca, IncBought (not open market)—

Companies traded

  • ERNA Ernexa Therapeutics Inc: other filings, last Aug 31, 2026
  • ERAS Erasca, Inc: 1 buy, last Jun 26, 2026
  • DCPH Deciphera Pharmaceuticals, Inc: 36 sales, last Jun 21, 2023

Get free alerts when James Arthur Bristol files a new trade →